

November 18, 2011
Shareholder Warren Woessner will be speaking on the Therasense and the future of the inequitable conduct defense at two American Conference Institute programs: The 14th Advanced Forum on Biotech Patents (Boston, Dec. 1st) and their program “Paragraph IV Disputes” (San Francisco December 7th).